Literature DB >> 12050380

Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.

Cristina de Carvalho Nicacio1, Marcelo Gonzalez Della Valle, Paula Padula, Ewa Björling, Alexander Plyusnin, Ake Lundkvist.   

Abstract

Hantaviruses are rodent-borne agents that cause hemorrhagic fever with renal syndrome or hantavirus pulmonary syndrome in humans. The nucleocapsid protein (N) is relatively conserved among hantaviruses and highly immunogenic in both laboratory animals and humans, and it has been shown to induce efficient protective immunity in animal models. To investigate the ability of recombinant N (rN) from different hantaviruses to elicit cross-protection, we immunized bank voles with rN from Puumala (PUUV), Topografov (TOPV), Andes (ANDV), and Dobrava (DOBV) viruses and subsequently challenged them with PUUV. All animals immunized with PUUV and TOPV rN were completely protected. In the group immunized with DOBV rN, 7 of 10 animals were protected, while only 3 of 8 animals were protected in the group immunized with ANDV rN, which is more closely related to PUUV rN than DOBV rN. Humoral and cellular immune responses after rN immunization were also investigated. The highest cross-reactive humoral responses against PUUV antigen were detected in sera from ANDV rN-immunized animals, followed by those from TOPV rN-immunized animals, and only very low antibody cross-reactivity was observed in sera from DOBV rN-immunized animals. In proliferation assays, T lymphocytes from animals immunized with all heterologous rNs were as efficiently recalled in vitro by PUUV rN as were T lymphocytes from animals immunized with homologous protein. In summary, this study has shown that hantavirus N can elicit cross-protective immune responses against PUUV, and the results suggest a more important role for the cellular arm of the immune response than for the humoral arm in cross-protection elicited by rN.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050380      PMCID: PMC136272          DOI: 10.1128/jvi.76.13.6669-6677.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Distribution and genetic heterogeneity of Puumala virus in Sweden.

Authors:  J Hörling; A Lundkvist; M Jaarola; A Plyusnin; H Tegelström; K Persson; H Lehväslaiho; B Hörnfeldt; A Vaheri; B Niklasson
Journal:  J Gen Virol       Date:  1996-10       Impact factor: 3.891

2.  Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells.

Authors:  O Vapalahti; A Lundkvist; H Kallio-Kokko; K Paukku; I Julkunen; H Lankinen; A Vaheri
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

3.  Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae.

Authors:  T Avsic-Zupanc; A Toney; K Anderson; Y K Chu; C Schmaljohn
Journal:  J Gen Virol       Date:  1995-11       Impact factor: 3.891

4.  Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins.

Authors:  X Xu; S L Ruo; J B McCormick; S P Fisher-Hoch
Journal:  Am J Trop Med Hyg       Date:  1992-10       Impact factor: 2.345

5.  Sensitive detection of hantaviruses by biotin-streptavidin enhanced immunoassays based on bank vole monoclonal antibodies.

Authors:  A Lundkvist; J Hörling; S Björsten; B Niklasson
Journal:  J Virol Methods       Date:  1995-03       Impact factor: 2.014

6.  Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome.

Authors:  C S Schmaljohn; S E Hasty; J M Dalrymple
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

7.  A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus.

Authors:  Y K Chu; G B Jennings; C S Schmaljohn
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity.

Authors:  A Lundkvist; H Kallio-Kokko; K B Sjölander; H Lankinen; B Niklasson; A Vaheri; O Vapalahti
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

9.  A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus.

Authors:  F Elgh; A Lundkvist; O A Alexeyev; G Wadell; P Juto
Journal:  J Virol Methods       Date:  1996-05       Impact factor: 2.014

10.  Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: definition of epitopes specific for acute immunoglobulin G recognition in humans.

Authors:  A Lundkvist; S Björsten; B Niklasson; N Ahlborg
Journal:  Clin Diagn Lab Immunol       Date:  1995-01
View more
  18 in total

Review 1.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

2.  Phosphorylation of the nucleocapsid protein of Hantaan virus by casein kinase II.

Authors:  Jeong-Joong Yoon; Yun-Tai Lee; Hin Chu; Seung-yeol Son; Manbok Kim
Journal:  J Microbiol       Date:  2015-05-03       Impact factor: 3.422

3.  Identification of three novel CTL epitopes within nucleocapsid protein of Hantaan virus.

Authors:  Meiliang Wang; Yong Zhu; Jiuping Wang; Tongde Lv; Boquan Jin
Journal:  Viral Immunol       Date:  2011-11-23       Impact factor: 2.257

4.  Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.

Authors:  R L Brocato; M J Josleyn; V Wahl-Jensen; C S Schmaljohn; J W Hooper
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

Review 5.  Human pathogenic hantaviruses and prevention of infection.

Authors:  Detlev H Krüger; Günther Schönrich; Boris Klempa
Journal:  Hum Vaccin       Date:  2011-06-01

Review 6.  New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention--a review.

Authors:  Martin Zeier; Michaela Handermann; Udo Bahr; Baldur Rensch; Sandra Müller; Roland Kehm; Walter Muranyi; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

7.  Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.

Authors:  Tobias Manigold; Andrés Mori; Rebecca Graumann; Elena Llop; Valeska Simon; Marcela Ferrés; Francisca Valdivieso; Constanza Castillo; Brian Hjelle; Pablo Vial
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

Review 8.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

9.  Induction of specific humoral and cellular immune responses in a mouse model following gene fusion of HSP70C and Hantaan virus Gn and S0.7 in an adenoviral vector.

Authors:  Linfeng Cheng; Lan Yu; Xingan Wu; Kai Li; Fang Wang; Liang Zhang; Wei Ye; Puyuan Li; Fanglin Zhang; Zhikai Xu
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

10.  HLA-A2 and B35 restricted hantaan virus nucleoprotein CD8+ T-cell epitope-specific immune response correlates with milder disease in hemorrhagic fever with renal syndrome.

Authors:  Ying Ma; Jiuping Wang; Bin Yuan; Meiliang Wang; Yun Zhang; Zhuwei Xu; Chunmei Zhang; Yusi Zhang; Bei Liu; Jing Yi; Kun Yang; Angang Yang; Ran Zhuang; Boquan Jin
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.